Avaliação econômica dos Programas Rede Farmácia de Minas do SUS versus Farmácia Popular do Brasil

• Autor(a) principal: Marina Morgado Garcia
• Data de Publicação: 2017
• Outros Autores: Augusto Afonso Guerra Júnior, Francisco de Assis Acurcio
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Repositório Institucional da UFMG
• Texto Completo: https://doi.org/10.1590/1413-81232017221.15912015; http://hdl.handle.net/1843/59540
• topic: Saúde pública; Economia da saúde; Acesso a medicamentos; Assistência farmacêutica; Saúde pública; Economia e organização da saúde; Acesso aos serviços de saúde; Assistência farmacêutica

We conducted an economic assessment of the Pharmaceutical Assistance - Rede Farmácia de Minas Gerais-RFMG and Farmácia Popular do Brasil-FPB to ascertain which of the two models stands out as the most efficient. To do this, a model, which consisted of a study of incurred costs in both programs, up to the dispensing of medicine to citizens, was developed. The uncertainties of the proposed model were tested using the Monte Carlo method. If the entire population initially estimated in the RFMG were attended in the FPB, there would be an additional cost of R$ 139,324,050.19. The sensitivity analysis appeared to be favorable to the RFMG. A total of 10000 simulations were carried out, resulting in a median value of R$ 114,053,709.99 for the RFMG and R$ 254,106,120.65 for the FPB. The current National Drug Policy emphasizes the need to strengthen pharmaceutical services beyond the mere acquisition and delivery of pharmaceutical products. The public healthcare service model, consistent with the principles and guidelines of the SUS, seems to be more appropriate in ensuring complete and universal quality healthcare services to the citizens. The economic study conducted reinforces this fact, as it appears to be a more efficient alternative of the direct use of resources in the public health network.